Palvella Therapeutics, Inc. (PVLA)

SEC filing

Palvella Therapeutics, Inc.

PVLA · CIK 1583648

4 · Aug 20, 2026 · Chief Operating Officer Goin Kathleen sold 4,302 shares at $152.21/share ($654.8K); exercised options for 8,604 shares

Chief Operating Officer Goin Kathleen sold 4,302 shares at $152.21/share ($654.8K); exercised options for 8,604 shares

OWNERSHIP DOCUMENT

xslF345X06/tm2623628-1_4seq1.xmlSEC.gov

Graphics and non-inline formats (not embedded below).